XML 41 R25.htm IDEA: XBRL DOCUMENT v2.4.1.9
Note 19 - Stock-based Compensation
12 Months Ended
Dec. 31, 2014
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]  
Disclosure of Compensation Related Costs, Share-based Payments [Text Block]
 

19.

Stock-based Compensation


The Company measures stock-based compensation expense for all stock-based compensation awards based on the grant-date fair value and recognizes the cost in the financial statements over the employee requisite service period.


The following table summarizes the consolidated stock-based compensation expense, by type of awards for the years ended December 31:


   

For the Years Ended

 
   

December 31, 2014

   

December 31, 2013

 

Employee stock options

  $ 332     $ 575  

Restricted stock grants

    24       -  

Total stock-based compensation expense

  $ 356     $ 575  

The following table summarizes the consolidated stock-based compensation by line items for the years ended December 31:


   

For the Years Ended

 
   

December 31, 2014

   

December 31, 2013

 

General and administrative

  $ 326     $ 429  

Sales, marketing and customer service

    30       100  

Engineering, design and product management

    -       46  

Total stock-based compensation expense

    356       575  

Tax effect on stock-based compensation expense

    -       -  

Total stock-based compensation expense after income taxes

  $ 356     $ 575  

As stock-based compensation expense recognized in the consolidated statements of operations is based on awards ultimately expected to vest, it has been reduced for estimated forfeitures. Forfeitures are required to be estimated at the time of grant and revised, if necessary, in subsequent periods if actual forfeitures differ from those estimates.


Determining Fair Value


Valuation and Amortization Method — The Company estimates the fair value of service-based and performance-based stock options granted using the Black-Scholes option-pricing formula. The fair value is then amortized on a straight-line basis over the requisite service periods of the awards, which is generally the vesting period. In the case of performance-based stock options, amortization does not begin until it is determined that meeting the performance criteria is probable. Service-based and performance-based options typically have a five to ten year life from date of grant and vesting periods of three to four years.


Expected Term — The Company’s expected term represents the period that the Company’s stock-based awards are expected to be outstanding. For awards granted subject only to service vesting requirements, the Company utilizes the simplified method for estimating the expected term of the stock-based award, instead of historical exercise data. For its performance-based awards, the Company has determined the expected term life to be five years based on contractual life and the seniority of the recipient.


Expected Volatility —The Company uses historical volatility of the price of its common shares to calculate the volatility for its granted options.


Expected Dividend — The Company has never paid dividends on its common shares and currently does not intend to do so, and accordingly, the dividend yield percentage is zero for all periods.


Risk-Free Interest Rate — The Company bases the risk-free interest rate used in the Black-Scholes valuation model upon the implied yield curve currently available on U.S. Treasury zero-coupon issues with a remaining term equal to the expected term used as the assumption in the model.


Assumptions used in the determination of the fair value of share-based payment awards using the Black-Scholes model for stock option grants during the years ended December 31 were as follows:


   

For the Years Ended

 
   

December 31, 2014

   

December 31, 2013

 

Expected term

            4                       3.75          

Risk-free interest rate

    1.39 %     -       1.85%       0.95 %     -       1.2%  

Expected volatility

    141 %     -       144%       106 %     -       118%  

Expected dividend yield

            0%                       0%          

Equity Incentive Plan


On November 15, 2006, subject to approval of the stockholders, the Company adopted the 2006 Equity Incentive Plan (the “Plan”) which permits the Company to grant stock options to directors, officers or employees of the Company or others to purchase shares of Common Stock of the Company through awards of incentive and nonqualified stock options (“Option”), stock (“Restricted Stock” or “Unrestricted Stock”) and stock appreciation rights (“SARs”). The Plan was approved by the stockholders on February 7, 2007.


The Company has granted time-based share options and restricted stock under the Plan to directors, officers, employees and individual consultants of the Company. The time-based options generally vest 25% annually and expire three to ten years from the date of grant. Total number of shares reserved and available for grant and issuance pursuant to this Plan is equal to 9% of the number of outstanding shares of the Company. Shares issued under the Plan will be drawn from authorized and unissued shares or shares now held or subsequently acquired by the Company. Outstanding shares of the Company shall, for purposes of such calculation, include the number of shares of stock into which other securities or instruments issued by the Company are currently convertible (e.g., convertible preferred stock, convertible debentures, or warrants for Common Stock), but not outstanding options to acquire stock. At December 31, 2014 there were 29,624,317 shares available for grant under the plan (9% of the outstanding shares of 568,847,967 plus outstanding warrants of 35,300,000 shares, plus 17,500,000 shares if converted from the convertible promissory note, less options outstanding and exercised since inception).


The exercise price of any Option will be determined by the Company when the Option is granted and may not be less than 100% of the fair market value of the shares on the date of grant, and the exercise price of any incentive stock option granted to a stockholder with a 10% or greater shareholding will not be less than 110% of the fair market value of the shares on the date of grant. The exercise price per share of a SAR will be determined by the Company at the time of grant, but will in no event be less than the fair market value of a share of Company’s stock on the date of grant.


The following table summarizes the Company’s stock option activities:


   

Shares

   

Weighted-

Average

Exercise

Price Per

Share

   

Weighted-

Average

Remaining

Contractual

Term

   

Aggregate

Intrinsic

Value

($000)

 

Outstanding as of January 1, 2013

    5,836,500     $ 0.45                  

Granted

    4,450,000       0.06                  

Exercised

                           

Forfeited

    (3,172,250 )     0.47                  

Outstanding as of December 31, 2013

    7,114,250       0.20                  

Granted

    24,345,000       0.88                  

Exercised

    (895,000

)

    0.22                  

Forfeited

    (5,135,250

)

    0.25                  

Outstanding as of December 31, 2014

    25,429,000       0.84       5.65     $ 30,302  

Vested and exercisable as of December 31, 2014

    1,492,000       0.44       1.92     $ 2,316  

Vested and expected to vest as of December 31, 2014

    16,871,918       0.57       5.46     $ 20,596  

The following table presents the exercise price and remaining life information about options exercisable at December 31, 2014:


 

Range of

exercise price

 

 

Shares

Exercisable

 

 

Weighted

average

remaining

contractual

life

 

 

Weighted

average

exercise

price

 

 

Aggregate

Intrinsic

($000)

 

$0.51

 -

$1.24

 

 

 

200,000

 

 

 

-

 

 

$

1.24

 

 

$

970

 

$0.30

 -

$0.50

 

 

 

792,000

 

 

 

1.32

 

 

 

0.48

 

 

 

1,196

 

$0.05

 -

$0.29

 

 

 

500,000

 

 

 

3.64

 

 

 

0.05

 

 

 

150

 

 

 

 

 

 

 

1,492,000

 

 

 

1.92

 

 

$

0.44

 

 

$

2,316

 


Changes in the Company’s non-vested stock awards are summarized as follows:


   

Time-based Options

   

Restricted Stock

 
   

Shares

   

Weighted

Average

Exercise

Price

Per Share

   

Shares

   

Weighted

Average

Grant Date

Fair Value

Per Share

 

Non-vested as of January 1, 2013

    4,227,000     $ 0.38       -     $ -  

Granted

    4,450,000       0.06       -          

Vested

    (802,750

)

    0.41       -          

Forfeited

    (2,195,500

)

    0.64       -          

Non-vested as of December 31, 2013

    5,678,750     $ 0.13       -       -  

Granted

    24,345,000       0.88       525,000       -  

Vested

    (1,708,500

)

    0.24       -       -  

Forfeited

    (4,378,250

)

    0.24       -       -  

Non-vested as of December 31, 2014

    23,937,000       0.84       525,000     $ -  

The total fair value of shares vested during the year ended December 31, 2014 and 2013 was $410 and $657, respectively. There were no changes to the contractual life of any fully vested options during the years ended December 31, 2014 and 2013.


Following is a summary of our restricted stock awards as of December 31, 2014 and 2013 and changes during the years then ended:


   

Number

of Shares

   

Weighted Average

Grant-Date

Fair Value

 

Restricted stock units at January 1, 2013

    1,325,868       0.63  

Granted

    -       -  

Forfeited

    -       -  

Restricted stock units at December 31, 2013

    1,325,868     $ 0.63  

Granted

    525,000       0.75  

Forfeited

    -       -  

Restricted stock units at December 31, 2014

    1,850,868       0.66